Louis G Lange sold $829K of NewAmsterdam Pharma (NAMS)

Executed Mar 6, disclosed Mar 10, 4 days later.

Value, as filed

$829K

28,186 sh × $29.41

Executed

Mar 6

the trade date, as filed

Disclosed

Mar 10

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Louis G Lange Director profile →

Louis G Lange (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in NewAmsterdam Pharma Company N.V. (NAMS). The largest single filing was $1.3M of NAMS (44,173 sh × $30.41, as filed), executed Mar 11.

The name

NAMS

NewAmsterdam Pharma Company N.V. NAMS · Healthcare · 45 filings in 24 months ticker →

Healthcare · NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with ca…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Louis G Lange in NAMS

NAMSSALE NewAmsterdam Pharma Company N.V. $1.3M
44,173 sh × $30.41
Exec Mar 11
Filed Mar 12 · 5:30 PM ET